BACKGROUND: Despite the growing epidemic of the metabolic syndrome (MetS), few studies have evaluated genetic polymorphisms associated with the MetS phenotype. One candidate, APOC3, modulates lipid and lipoprotein metabolism and the promoter polymorphisms C-482T/T-455C are associated with loss of insulin downregulation. METHODS: One hundred twenty two consecutive MetS cases were matched by age, sex and race in a 1:1 case-control design to evaluate the prevalence of common polymorphisms in the following candidate genes: APOC3, APOE, B3AR, FABP2, GNB3, LPL, and PPARalpha and PPARgamma. RESULTS: Compared to controls, MetS subjects exhibited a greater prevalence of APOC3 promoter polymorphisms. Specifically, the frequency of the variant C-482T and T-455C alleles was 70.5 and 81.9% of cases compared to 43.4 and 54.1% in controls, respectively (p <0.0001). Overall, APOC3 promoter variants were associated with a greater likelihood of MetS compared to wild type [C-482T (OR: 4.3; 95% CI: 2.2, 8.6 [p <0.0001]), T-455C (OR: 3.6; 95% CI: 2.0, 6.7 [p <0.0001])]. No material differences were identified between the other genetic variants tested and prevalence of MetS. CONCLUSIONS: These data, therefore, suggest that the APOC3 promoter polymorphisms C-482T and T-455C are associated with the MetS.
BACKGROUND: Despite the growing epidemic of the metabolic syndrome (MetS), few studies have evaluated genetic polymorphisms associated with the MetS phenotype. One candidate, APOC3, modulates lipid and lipoprotein metabolism and the promoter polymorphisms C-482T/T-455C are associated with loss of insulin downregulation. METHODS: One hundred twenty two consecutive MetS cases were matched by age, sex and race in a 1:1 case-control design to evaluate the prevalence of common polymorphisms in the following candidate genes: APOC3, APOE, B3AR, FABP2, GNB3, LPL, and PPARalpha and PPARgamma. RESULTS: Compared to controls, MetS subjects exhibited a greater prevalence of APOC3 promoter polymorphisms. Specifically, the frequency of the variant C-482T and T-455C alleles was 70.5 and 81.9% of cases compared to 43.4 and 54.1% in controls, respectively (p <0.0001). Overall, APOC3 promoter variants were associated with a greater likelihood of MetS compared to wild type [C-482T (OR: 4.3; 95% CI: 2.2, 8.6 [p <0.0001]), T-455C (OR: 3.6; 95% CI: 2.0, 6.7 [p <0.0001])]. No material differences were identified between the other genetic variants tested and prevalence of MetS. CONCLUSIONS: These data, therefore, suggest that the APOC3 promoter polymorphisms C-482T and T-455C are associated with the MetS.
Authors: D M Waterworth; P J Talmud; S E Humphries; P D Wicks; G A Sagnella; P Strazzullo; K G Alberti; D G Cook; F P Cappuccio Journal: Diabetologia Date: 2001-02 Impact factor: 10.122
Authors: M E Samuels; K C Forbey; J E Reid; V Abkevich; K Bulka; B R Wardell; B R Bowen; P N Hopkins; S C Hunt; D G Ballinger; M H Skolnick; S Wagner Journal: Clin Genet Date: 2001-02 Impact factor: 4.438
Authors: G T Russo; J B Meigs; L A Cupples; S Demissie; J D Otvos; P W Wilson; C Lahoz; D Cucinotta; P Couture; T Mallory; E J Schaefer; J M Ordovas Journal: Atherosclerosis Date: 2001-09 Impact factor: 5.162
Authors: Wilfried Renner; Michael M Hoffmann; Gerda Grünbacher; Bernhard R Winkelmann; Bernhard O Boehm; Winfried März Journal: Atherosclerosis Date: 2006-08-14 Impact factor: 5.162
Authors: Dolores Corella; Marisa Guillén; Carmen Sáiz; Olga Portolés; Antonio Sabater; José Folch; Jose M Ordovas Journal: J Lipid Res Date: 2002-03 Impact factor: 5.922
Authors: Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel Journal: Endocr Rev Date: 2008-10-29 Impact factor: 19.871
Authors: Kati Kristiansson; Markus Perola; Emmi Tikkanen; Johannes Kettunen; Ida Surakka; Aki S Havulinna; Alena Stancáková; Chris Barnes; Elisabeth Widen; Eero Kajantie; Johan G Eriksson; Jorma Viikari; Mika Kähönen; Terho Lehtimäki; Olli T Raitakari; Anna-Liisa Hartikainen; Aimo Ruokonen; Anneli Pouta; Antti Jula; Antti J Kangas; Pasi Soininen; Mika Ala-Korpela; Satu Männistö; Pekka Jousilahti; Lori L Bonnycastle; Marjo-Riitta Järvelin; Johanna Kuusisto; Francis S Collins; Markku Laakso; Matthew E Hurles; Aarno Palotie; Leena Peltonen; Samuli Ripatti; Veikko Salomaa Journal: Circ Cardiovasc Genet Date: 2012-03-07
Authors: Karen D Corbin; Manal F Abdelmalek; Melanie D Spencer; Kerry-Ann da Costa; Joseph A Galanko; Wei Sha; Ayako Suzuki; Cynthia D Guy; Diana M Cardona; Alfonso Torquati; Anna Mae Diehl; Steven H Zeisel Journal: FASEB J Date: 2013-01-04 Impact factor: 5.191